The path to developing a cervical cancer vaccine.
The path that led me to where I am today in my career as a vaccinologist was not a straight one: it was riddled with twists and turns, opportunities and obstacles and full of decisions that could have taken me down very different avenues. Working and interacting with many dedicated and brilliant scientists and taking apprenticeships to become a better and more versatile scientist have been rewarding experiences and more than once luck has come into play.
Jansen
Kathrin U
KU
Vaccine Research & Early Development, Pfizer Inc., USA. kathrin.jansen@pfizer.com
D005260:Female; D049673:History, 20th Century; D049674:History, 21st Century; D006801:Humans; D053918:Papillomavirus Vaccines / Q000266:history* / Q000276:immunology*; D002583:Uterine Cervical Neoplasms / Q000453:epidemiology / Q000517:prevention & control*
D053918:Papillomavirus Vaccines